% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Chen:878125,
author = {Chen, Xiangliang and Laurent, Sarah and Onur, Oezguer A.
and Kleineberg, Nina N. and Fink, Gereon R. and Schweitzer,
Finja and Warnke, Clemens},
title = {{A} systematic review of neurological symptoms and
complications of {COVID}-19},
journal = {Journal of neurology},
volume = {268},
number = {2},
issn = {0340-5354},
address = {Berlin},
publisher = {Springer85301},
reportid = {FZJ-2020-02643},
pages = {392-402},
year = {2021},
abstract = {ObjectiveTo study the frequency of neurological symptoms
and complications in COVID-19 patients in a systematic
review of the literature.MethodsRelevant studies were
identified through electronic explorations of PubMed,
medRxiv, and bioRxiv. Besides, three Chinese databases were
searched. A snowballing method searching the bibliographies
of the retrieved references was applied to identify
potentially relevant articles. Articles published within 1
year prior to April 20th, 2020, were screened with no
language restriction imposed. Databases were searched for
terms related to SARS-CoV-2/COVID-19 and neurological
manifestations, using a pre-established protocol registered
on the International Prospective Register of Systematic
Reviews database (ID: CRD42020187994).ResultsA total of 2441
articles were screened for relevant content, of which 92
full-text publications were included in the analyses of
neurological manifestations of COVID-19. Headache,
dizziness, taste and smell dysfunctions, and impaired
consciousness were the most frequently described
neurological symptoms, the latter more often among patients
with a severe or critical disease course. To date, only
smaller cohort studies or single cases have reported
cerebrovascular events, seizures, meningoencephalitis, and
immune-mediated neurological diseases, not suitable for
quantitative analysis.ConclusionThe most frequent
neurological symptoms reported in association with COVID-19
are non-specific for the infection with SARS-CoV-2. Although
SARS-CoV-2 may have the potential to gain direct access to
the nervous system, so far, SARS-CoV-2 was detected in the
cerebrospinal fluid in two cases only. Standardized
international registries are needed to clarify the clinical
relevance of the neuropathogenicity of SARS-CoV-2 and to
elucidate a possible impact of SARS-CoV-2 infection on
common neurological disease, such as Alzheimer’s,
Parkinson’s disease or multiple sclerosis.},
cin = {INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {32691236},
UT = {WOS:000550621700002},
doi = {10.1007/s00415-020-10067-3},
url = {https://juser.fz-juelich.de/record/878125},
}